ARTICLE | Clinical News
Advantage 24 nonoxynol-9 in Bioadhesive Delivery System: The United Nations Global Program on HIV/AIDS began a Phase III study
May 20, 1996 7:00 AM UTC
Columbia Laboratories Inc. (COB), Miami, Fla. Product: Advantage 24 nonoxynol-9 in Bioadhesive Delivery System Indication: Prevent transmission of HIV and sexually transmitted diseases Status: The Un...